Authors: Shechter, Y Goldwaser, I Lavon, I Gershonov, E Mester, B Mironchik, M Patt, LP Fridkin, M

Citation: Y. Shechter et al., A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo, DRUG FUTURE, 26(7), 2001, pp. 669-676

Authors: Sun, Q Sekar, N Goldwaser, I Gershonov, E Fridkin, M Shechter, Y

Citation: Q. Sun et al., Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism, AM J P-ENDO, 279(2), 2000, pp. E403-E410

Authors: Goldwaser, I Gefel, D Gershonov, E Fridkin, M Shechter, Y

Citation: I. Goldwaser et al., Insulin-like effects of vanadium: basic and clinical implications, J INORG BIO, 80(1-2), 2000, pp. 21-25

Authors: Goldwaser, I Qian, S Gershonov, E Fridkin, M Shechter, Y

Citation: I. Goldwaser et al., Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: Establishing criteria for optimal chelators, MOLEC PHARM, 58(4), 2000, pp. 738-746

Authors: Gershonov, E Goldwaser, I Fridkin, M Shechter, Y

Citation: E. Gershonov et al., A novel approach for a water soluble long-acting insulin prodrug: Design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin, J MED CHEM, 43(13), 2000, pp. 2530-2537

Authors: Goldwaser, I Li, JP Gershonov, E Armoni, M Karnieli, E Fridkin, M Shechter, Y

Citation: I. Goldwaser et al., L-glutamic acid gamma-monohydroxamate - A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo, J BIOL CHEM, 274(37), 1999, pp. 26617-26624